Research Area
Product Type
United States ( Change Country )
VX-745 Chemical Structure
Recommended Products
SB 203580
SB 203580 is a potent inhibitor of LPS-induced cytokine synthesis in the human monocyte cell line THP-1 (IC50 = 50-100 nM).
SB 202190
SB 202190 is a P38 MAP(mitogen activated protein) Kinase inhibitor.
LY2228820
LY2228820 is a novel and potent p38MAPK inhibitor (the IC50 for p38αMAPK and p38βMAPK were 7 nM and 3 nM, respectively).
Vinorelbine (Navelbine)
Vinorelbine (Navelbine) is the first 5´NOR semi-synthetic vinca alkaloid and exerts its activity through the MAPK (p38) pathway with median IC90 and IC50 of 15.5 and 2.3 μM.
BIRB 796 (Doramapimod)
BIRB 796 (Doramapimod) is a highly selective p38α MAPK inhibitor of TNF-α with EC50 of 18 nM in THP-1 cells.
PH-797804
PH-797804 is a highly selective, potent, and ATP-competitive p38 MAP kinase inhibitor with an IC50 of 2.3 nM.
VX-702
VX-702 is a highly selective, orally active inhibitor of p38 MAPKα with an IC50 range of 4 to 20 nM for human platelets.
AZD6244 (Selumetinib)
AZD6244 (Selumetinib, ARRY-142886) is highly potent to inhibit MEK1 with IC50 of 14 nM.
CI-1040 (PD184352)
CI-1040 (PD184352) is a MEK 1/2 inhibitor. Ki of 300nM
PD0325901
PD0325901 is MEK inhibitor and non-competitive with ATP, Kiapp of 1 nM against activated MEK1 and MEK2.
Biological Activity
| Information | VX-745 is a potent and selective inhibitor to p38α and p38β MAPK with IC50 of 10 nM and 220 nM, respectively. | |||||
|---|---|---|---|---|---|---|
| Targets | p38α MAPK | p38β MAPK | ||||
| IC50 | 10 nM [1] | 220 nM [1] | ||||
| In vitro | VX-745 selectively inhibits p38α and p38β MAPK with IC50 of 10 nM and 220 nM, respectively, but not p38γ MAPK and a large panel of other kinases, with IC50 larger than 20 µM. In a human peripheral blood mononuclear cell (PBMC) assay, VX-745 provides IC50 of 56 and 52 nM for IL-1β and TNFα, respectively. VX-745 blocks IL-6 and IL-8 production induced by IL-1 and TNFα, and COX-2 synthesis mediated by LPS and IL-1β. [1-3] VX-745 (60 nM–20 µM) inhibits IL-6 and VEGF secretion in bone marrow stromal cells (BMSCs), without affecting their viability. VX-745 also inhibits TNF-α–induced IL-6 secretion in BMSCs. VX-745 inhibits both multiple myeloma (MM) cell proliferation and IL-6 secretion in BMSCs triggered by adherence of MM cells to BMSCs, suggesting that VX-745 can inhibit paracrine multiple myeloma (MM) cell growth in the BM milieu and overcome cell adhesion-related drug resistance. [4] | |||||
| In vivo | VX-745 is effective against adjuvant-induced arthritis (AA) in the rat with ED50 of 5 mg/kg. Histological scores for VX-745 in AA rats are 93% inhibition of bone resorption and 56% inhibition of inflammation. In the classical cartilage-induced arthritis model, VX-745 exhibits a dose-responsive decrease in severity score. [1-3] In a type II collagen-induced arthritis (CIA) mice model, VX-745 (2.5, 5, and 10 mg/kg) has 27%, 31%, and 44% improvement in the inflammatory scores, respectively, when compared to vehicle-treated mice. In addition, histological scores show a 32–39% protection of bone and cartilage erosion by VX-745. [5] | |||||
| Clinical Trials | ||||||
| Features | VX-745 is a potent and selective inhibitor to p38α and p38β MAPK. | |||||
Protocol
Kinase Assay: [5]
| Spectrophotometric coupled-enzyme assay | The IC50 for the inhibition of p38α and p38β homologs are obtained by a spectrophotometric coupled-enzyme assay. A fixed concentration of enzyme (15 nM of p38α or p38β) is incubated with VX-745 in DMSO for 10 min. at 30℃ in 0.1 M HEPES buffer, pH 7.5, containing 10% glycerol, 10 mM MgCl2, 2.5 mM phosphoenolpyruvate, 200 µM NADH, 150 µg/mL pyruvate kinase, 50 µg/mL lactate dehydrogenase, and 200 µM EGF receptor peptide (KRELVEPLTPSGEAPNQALLR). The reaction is initiated with 100 µM and 70 µM ATP for p38α and p38β assays, respectively. The decrease of absorbance at 340 nm is monitored to follow the rate of the reaction. IC50 is evaluated from the rate data as a function of the inhibitor concentration. |
|---|
Cell Assay: [4]
| Cell lines: | Human bone marrow stromal cells (BMSCs) and multiple myeloma (MM) cells |
|---|---|
| Concentrations: | 60 nM–20 μM, dissolved in DMSO. |
| Incubation Time: | 48 hours |
| Method: | BMSCs (5 × 104 cells/well) or MM cells (3 × 104 cells/well) are incubated in 96-well culture plates in the presence or absence of VX-745 for 48 hours at 37 ℃. DNA synthesis is measured by [3H]-thymidine ([3H]TdR) uptake. Cells are pulsed with [3H]TdR (0.5 μCi/well [.0185 MBq]) during the last 8 hours of 48-hour cultures. Growth inhibition of both MM cells and BMSCs by VX-745 is also assessed by measuring 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) dye absorbance. |
Animal Study:[5]
| Animal Models: | Type II collagen-induced arthritis (CIA) mice model (DBA/1J) |
|---|---|
| Formulation: | Dissolved in 100% polyethylene glycol |
| Dosages: | 2.5, 5, and 10 mg/kg |
| Administration: | Oral gavage twice daily |
Chemical Information
| Molecular Weight (WM): | 436.26 |
|---|---|
| Formula: | C19H9Cl2F2N3OS |
| CAS No.: | 209410-46-8 |
| Synonyms: |
N/A
|
| Dissolve in (25°C): | DMSO ≥63mg/mL |
| Water <1mg/mL | |
| Ethanol <1mg/mL | |
| Storage: | 2 years-20°CPowder |
| 1 week-4°Cin DMSO | |
| 1 month-80°in DMSO |
Quality Control & MSDS
Research Area
Notes:
Related Inhibitors
Recommended Screening Libraries
Chemical Library
A collection of 864 bioactive compounds
Inhibitor Library
A collection of 481 inhibitors
Kinase Inhibitor Library
A collection of 194 kinase inhibitors
Tyrosine Kinase Inhibitor Library
A collection of 85 tyrosine kinase inhibitors.
FDA Approved Drug Library
A collection of 426 FDA approved drugs
Natural Product Library
A collection of 139 natural products
Chemotherapeutic Agent Library
A collection of 40 chemotherapeutic agents
Epigenetics Compound library
A unique collection of 17 small molecule modulators
Stem Cell Compound library
A unique collection of 47 small molecule inhibitors
GPCR Compound library
A unique collection of 63 GPCR small molecules
Keywords:buy VX-745 | VX-745 supplier | purchase VX-745 | VX-745 cost | VX-745 manufacturer | order VX-745 | VX-745 distributor